Longyear Health December 16, 2025
A quick primer on the current state of affairs with GLP-1s and Health AI
Medicine stands at a remarkable inflection point. Two distinct technological advances exemplify the rapid pace of change in health technologies—artificial intelligence (AI) and glucagon-like peptide-1 receptor agonists. While GLP-1s are very specific, AI encompasses a wide range of large language models, machine learning algorithms, and deep learning techniques.
These innovations share more than temporal coincidence; both represent paradigm shifts that challenge traditional approaches to care delivery while promising unprecedented improvements in patient outcomes. Understanding their trajectories, applications, and implications is essential for health care stakeholders navigating this transformation. These technologies may also be indicative of future medical progress which should prompt us to rethink our care...
Today's Sponsors
Today's Sponsor